HOME >> MEDICINE >> NEWS
The Lancet Oncology (TLO)

Billions of dollars are currently being spent on the search for effective drugs that will stop disease before it happens. Advances in genetic testing are providing more opportunities to find out which diseases people are likely to be at risk of developing--but this knowledge has put huge pressure on the medical profession to come up with ways of avoiding disease altogether. This month's leading edge questions the ethical issues involved in chemoprevention and highlights the difficulties in obtaining reliable data from chemoprevention clinical trials. It concludes: "Genetic tests have created a demand for chemoprevention that is threatening to push medicine to its limits; health services could be stretched beyond capacity because they are treating healthy people as well as the sick. To stop this snowball effect it is essential that one simple idea is kept in mind: you can spend all the money in the world on preventive medicine, but when people won't even stop smoking, can it really work?"

STOMACH CANCER - THE LATEST TARGET FOR THE 'MAGIC BULLET'

Gastrointestinal stromal tumours (GISTs) are the most recent cancer type to be targeted by the most effective new drug of recent years--imatinib mesylate. Effective treatment of GISTs has been hindered in the past by their characteristic resistance to conventional chemotherapy and persistent misclassification of these tumours in clinical studies has made pre-2000 data difficult to interpret. However, it is now known that most GISTs contain a mutation in the KIT tyrosine kinase, which means they are an ideal target for imatinib. In their review, Heikki Joensuu and colleagues discuss the recent advances in understanding of these difficult-to-treat tumours and discusses the impact of imatinib on outcome for patients with GISTs. The authors conclude that imatinib "has provided physicians with a well-tolerated and highly effective therapeutic option for a disease for which no systemic therapy existed previously".
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
30-Oct-2002


Page: 1 2

Related medicine news :

1. The Lancet calls for the creation of a world institute for risk evaluation
2. The Lancet calls for creation of Intl Commission on Global Responses to Complex Emergencies
3. Majority of authors retract 1998 Lancet paper-Lancet editor points to implications
4. The Lancet Infectious Diseases (TLID)
5. The Lancet Neurology November press release
6. Lancet readers to join WHO election debate
7. The Lancet Oncology press release
8. The Lancet Neurology October press release
9. The Lancet neurology press release
10. The Lancet Neurology press release
11. The Lancet Oncology (TLO) and the Lancet Infectious Diseases (TLID)

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: The Lancet Oncology TLO

(Date:7/29/2015)... ... , ... A June 10, 2015 article from the News-Press, entitled " It's ... having regular skin cancer screenings from an early age. Skin cancer can strike at ... early, skin cancer is rarely fatal; however, if left alone for too long, the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Employee Fiduciary, LLC announces the launch of ... information, website, types of plans administered, years in business, and credentials of all Employee ... least one plan with Employee Fiduciary. A search can be done by zip code ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Several years ... population of children with autism, Little City took a proactive stance and began planning ... The Coleman Foundation grant provides valuable support to building the third home. , “We ...
(Date:7/29/2015)... ... July 29, 2015 , ... Attorneys representing American families in ... Lawsuit Center. The website now features a page dedicated to news related to pending ... sources. The Talcum Powder Lawsuit News page was launched with eight initial ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... thinker.” Since the late 1970s, Dr. Cottrell has been making predictions about the ... New Earth, documents many of these prognostications. He warns that extreme weather conditions ...
Breaking Medicine News(10 mins):Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Employee Fiduciary Launches Financial Advisor Directory 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 2Health News:National Attorneys Provide Regular Talcum Powder Lawsuit News Updates 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2
(Date:7/29/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ... "Global Wound Care Markets (Twelve Country Analysis: Germany, ... China, India, Brazil, Australia, South Korea)" report ... provides a competitive market summary. The wound care ... offerings and product maturity. Several of the products ...
(Date:7/29/2015)... BURLINGTON, Mass. , July 29, 2015   ... device market in Europe will ... unfavorable economic conditions across the Eurozone. On a longer ... the elderly, obese, and physically active will increase the ... treatment via arthroscopy devices and orthopedic soft tissue solutions. ...
(Date:7/29/2015)... Juli 2015 In der klinischen ... die tägliche Einnahme des L. reuteri ... anreichert und die Darmproduktion von Proteinfaktoren verändert, ... die tägliche Einnahme von Nutraceutix, L. ... Verwendung der patentierten Verabreichungstechnologie BIO- tract ®, ...
Breaking Medicine Technology:Global Wound Care Markets 2015 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 2The Long-Term Outlook for European Sports Medicine Device Markets Remains Positive, with Economic Recovery and Expanding Patient Populations Supporting Growth Through 2023 3Klinischer Nachweis erbracht, dass L. reuteri Probiotikum von Nutraceutix den Darm-Insulinmetabolismus moduliert 2
Cached News: